Chronic Myeloid Leukemia Chronic Phase
📧 Sign up to get email alerts when something new happens for Chronic Myeloid Leukemia Chronic Phase.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: A Study of Treatment-free Remission in Chronic Phase Chronic Myeloid Leukemia [Phase 2]
A Phase 2 clinical trial in chronic myeloid leukemia, chronic phase, evaluating treatment-free remission, is currently recruiting in Korea.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Dasatinib and Venetoclax in Treating Patients With Philadelphia Chromosome Positive or BCR-ABL1 Positive Early Chronic Phase Chronic Myelogenous Leukemia [Phase 2]
Phase 2 clinical trial evaluating the combination of dasatinib and venetoclax in patients with early chronic-phase Philadelphia chromosome-p…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: RWE,NIS,Prospective Study for the Effectiveness, Tolerability and Adherence of Asciminib in Saudi Arabia. (ASC4REAL)
Novartis is conducting ASC4REAL, a prospective real-world study of Asciminib in Saudi Arabia to evaluate effectiveness, tolerability, and ad…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Managed Access Programs for ABL001, Asciminib
The update describes managed access programs for asciminib (ABL001). These programs are intended to provide patient access for chronic myelo…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Ponatinib in Chronic Myeloid Leukemia Patients in Chronic Phase
This clinical trial update notes recruitment for ponatinib in patients with chronic myeloid leukemia in chronic phase at the University of P…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-12-31Clinical Trial Update: Study to Evaluate the Reinduction and Second Stop of TKI with Ponatinib in CML in Molecular Response (ResToP) [Phase 2]
Phase 2 clinical trial update for the ResToP study evaluating reinduction and a second stop of ponatinib therapy in chronic phase chronic my…
-
CLINICAL_TRIALS research · 2024-10-28Clinical Trial Update: Randomized Evaluation of Radotinib Versus Imatinib in Phase III Study for Efficacy With Chinese Patients (RERISE China) [Phase 3]
Phase III randomized study evaluating radotinib versus imatinib in Chinese patients with chronic myeloid leukemia, chronic phase. The study …